摘要
目的探讨电化学发光免疫分析(ECLIA)定量检测乙肝标志物的临床意义。方法采用ECLIA法定量检测361例乙肝患者的HBsAg、抗-HBs、HBeAg、抗-HBe、抗-HBc水平,分析其与HBV-DNA水平、肝功能检测结果、临床分型的相关性。结果 HBsAg、HBeAg与HBV-DNA定量呈正相关(r=0.6336,0.4032,P<0.01),HBsAb、HBeAb、HBcAb与HBV-DNA定量呈负相关(r=-0.2582,-0.3864、-0.3568,P<0.01);乙肝标志物定量检测与患者肝功能指标均无相关性(P>0.05);HBsAg、HBeAg、抗-HBc含量在急性乙肝和亚急性重症乙肝患者中较慢性乙肝、慢性重型乙肝和肝硬化患者低(P<0.05)。结论 ECLIA定量检测乙肝病毒血清学标志物含量可反映乙肝病毒的复制水平,定量检测结果与肝功能异常无明显关联,但与临床分型相关。
Objective To discuss the clinical value of electrochemiluminescence immune assay (ECLIA) in the detection of hepatitis B markers. Methods ECLIA was used to quantitatively detect the levels of HBsAg, anti - HBs, HBeAg, anti - HBe, and anti - HBe in 361 patients with hepatitis B. Analysis was made in the correlation between those indexes and the level of HBV - DNA, examination results of liver function,ad clinical classification. Results There was a positive correlation between the levels of HBsAg and HBeAg and the quantitation of HBV - DNA( r = O. 6336,0. 4032 ,P 〈 O. O1 ). There was a negative correlation between the levels of HBsAb,HBeAb,and HBeAb and the quantitation of HBV - DNA ( r = - O. 2582, - 0. 3864, - O. 3568, P 〈 0. O1 ). There was no correlation between the levels of hepatitis B markers and the indexes of liver function( P 〉 0.05 ). The levels of HBsAg, HBeAg, and anti - HBc in patients with acute hepatitis B and sub - acute gravis hepatitis B were lower than those in patients with chronic hepatitis B, chronic gravis hepatitis B, and cirrhosis ( P 〈 O. 05 ). Conclusion The quantitative detection of serologic marker levels in hepatitis B virus by ECLIA can show the replication ability of this virus. The quantitative detection results have no significant correlation with liver dysfunction, but are correlated with the clinical classification.
出处
《西南国防医药》
CAS
2012年第7期767-769,共3页
Medical Journal of National Defending Forces in Southwest China
关键词
电化学发光免疫分析
乙肝标记物
检测
临床价值
electrochemiluminescence immune assay
hepatitis B marker
detection
clinical value